Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast CancerCompleted
NCT00885755Phase 2Updated Mar 29, 2018
Sponsor: Hoffmann-La Roche
Breast Cancer
Australia, Spain, Sweden, United Kingdom
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.Completed
NCT00435929Phase 1Updated Mar 29, 2018
Sponsor: Hoffmann-La Roche
HIV Infections
United States, Canada, Puerto Rico
Capecitabine For Nasopharyngeal CancerCompleted
NCT00095901Phase 2Updated Mar 29, 2018
Sponsor: Dana-Farber Cancer Institute
Head and Neck Cancer
United States
A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDsCompleted
NCT01034397Phase 4Updated Mar 29, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Portugal
IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft RecipientsCompleted
NCT00294515Phase 3Updated Mar 29, 2018
Sponsor: Hoffmann-La Roche
Cytomegalovirus Infections
United States, Australia, Belgium, Brazil, Canada +8 more
A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric CancerCompleted
NCT01839500N/AUpdated Mar 29, 2018
Sponsor: Hoffmann-La Roche
Gastric Cancer
China
A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or AdenotonsillectomyCompleted
NCT00231478Phase 4Updated Mar 27, 2018
Sponsor: Hoffmann-La Roche
Post-Operative Nausea and Vomiting
United States
A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast CancerCompleted
NCT01094184Phase 4Updated Mar 22, 2018
Sponsor: Hoffmann-La Roche
Breast Cancer
United Kingdom
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With PolyangiitisTerminated
NCT02626845Phase 4Updated Mar 22, 2018
Sponsor: Hospital for Special Surgery, New York
Granulomatosis With Polyangiitis (Wegener's Granulomatosis)
United States
A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic StatusTerminated
NCT01271010Phase 4Updated Mar 20, 2018
Sponsor: Hoffmann-La Roche
Lymphocytic Leukemia, Chronic
Russia
Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in PakistanCompleted
NCT02444845N/AUpdated Mar 20, 2018
Sponsor: Hoffmann-La Roche
Anemia, Diabetes, Kidney Disease, Chronic, Hypertension
Pakistan
A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Participants With Advanced Cervical CancerCompleted
NCT03071848N/AUpdated Mar 16, 2018
Sponsor: Hoffmann-La Roche
Cervical Cancer
Argentina
A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast CancerCompleted
NCT01142778Phase 2Updated Mar 16, 2018
Sponsor: Hoffmann-La Roche
Breast Cancer
France
A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid TumorsCompleted
NCT01494688Phase 1Updated Mar 16, 2018
Sponsor: Hoffmann-La Roche
Advanced Solid Tumors
United States, France
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).Completed
NCT02622334Phase 1Updated Mar 14, 2018
Sponsor: Hoffmann-La Roche
Glaucoma
United States, Singapore
Local Excision in Downstaged Rectal CancerCompleted
NCT00427375Phase 3Updated Mar 14, 2018
Sponsor: University Hospital, Bordeaux
Rectal Neoplasms
France
Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.Completed
NCT00963534Phase 1, Phase 2Updated Mar 12, 2018
Sponsor: Lund University Hospital
Mantle Cell Lymphoma
Denmark, Finland, Norway, Sweden
To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis BUnknown
NCT02982837Phase 4Updated Mar 9, 2018
Sponsor: King Abdullah International Medical Research Center
Hepatitis B
Saudi Arabia
GA In NEwly Diagnosed Diffuse Large B Cell LymphomaTerminated
NCT01659099Phase 3Updated Mar 7, 2018
Sponsor: The Lymphoma Academic Research Organisation
Diffuse Large B Cell Lymphoma CD20 Positive
Belgium, France
A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid TumorsCompleted
NCT02004106Phase 1Updated Mar 6, 2018
Sponsor: Hoffmann-La Roche
Neoplasms
United States, Denmark, Finland, France, Netherlands +3 more
A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid ArthritisCompleted
NCT01770834N/AUpdated Mar 2, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Kuwait, Lebanon, Qatar, United Arab Emirates
A Study of Mircera in Anemic Patients With Multiple MyelomaCompleted
NCT00360347Phase 1, Phase 2Updated Mar 1, 2018
Sponsor: Hoffmann-La Roche
Anemia
Czechia, Poland
An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis CCompleted
NCT01679834N/AUpdated Mar 1, 2018
Sponsor: Hoffmann-La Roche
Hepatitis C, Chronic
Germany
An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second RelapseCompleted
NCT01618747N/AUpdated Feb 28, 2018
Sponsor: Hoffmann-La Roche
Glioblastoma Multiforme
Taiwan
A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28)Completed
NCT02534311N/AUpdated Feb 28, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Slovakia

Previous page Next page